About Glenn Biggs
Known for his dedication and service to the community, Glenn Biggs was a prominent figure whose leadership influenced economic development across San Antonio. When he was diagnosed with Alzheimer’s disease, he and his family struggled to find comprehensive care. This search led him to approach UT Health San Antonio President William L. Henrich, M.D., MACP, and many other community leaders to address the need for a comprehensive center dedicated to understanding Alzheimer’s disease. His vision of a center to transform care and advance discovery became what is today known as the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio.
Physicians, researchers, faculty and staff working together to provide comprehensive care with the vision of restoring function and hope to millions.
Help advance dementia care
We are expanding our enrichment programs to better serve our patients and their caregivers. Volunteers are needed to help at events as we can continue to bring more programs to our community.
We are expanding the understanding of dementia by learning how biological and environmental factors influence health. You can help by signing up to provide biological samples, like blood, during your routine exams.
Clinical trial volunteer
Volunteers from all health backgrounds are needed to help us learn more about dementia. As a healthy clinical trial volunteer, your participation may include one or two clinical visits overtime or providing a one-time sample of blood.
When a person donates, they are helping find better ways to diagnose and treat millions of people living with dementia. Some of the most exciting advances and discoveries come from studying brain tissue, which is why we need your help.
“UT Health San Antonio has the passion and vision. Because of the inspiration from Glenn Biggs, Dr. Henrich had a grand vision that also matched what I wanted to do. The grandness of this vision makes our likelihood for success greater.”
Sudha Seshadri, M.D., D.M., founding director of the Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases